APYX MEDICAL CORP (APYX) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:APYX • US03837C1062

3.94 USD
-0.03 (-0.76%)
Last: Feb 5, 2026, 04:30 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
APYX revenue by date.APYX revenue by date.
44.51M
-8.26%
52.349M
17.61%
48.102M
-8.11%
52.606M
9.36%
56.131M
6.70%
59.913M
6.74%
74.072M
23.63%
272.59M
268.01%
361.19M
32.50%
EBITDA
YoY % growth
APYX ebitda by date.APYX ebitda by date.
-22.67M
-67.31%
-19.259M
15.05%
-18.246M
5.26%
-4.791M
73.74%
-7.669M
-60.08%
-5.147M
32.88%
14.178M
375.44%
N/AN/A
EBIT
YoY % growth
APYX ebit by date.APYX ebit by date.
-23.56M
-63.04%
-19.951M
15.32%
-18.845M
5.54%
-7.676M
59.27%
-11.111M
-44.74%
-10.082M
9.26%
3.704M
136.74%
40.889M
1,003.91%
72.237M
76.67%
Operating Margin
APYX operating margin by date.APYX operating margin by date.
-52.93%-38.11%-39.18%-14.59%-19.79%-16.83%5.00%15.00%20.00%
EPS
YoY % growth
APYX eps by date.APYX eps by date.
-0.67
-52.27%
-0.62
7.46%
-0.67
-8.06%
-0.32
52.43%
-0.37
-16.80%
-0.34
9.59%
-0.03
90.91%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.06
47.09%
-0.12
-17.30%
-0.10
-10.50%
-0.09
-83.60%
-0.06
-0.80%
-0.10
11.30%
-0.09
5.64%
-0.10
-12.22%
-0.09
-35.46%
Revenue
Q2Q % growth
18.237M
28.23%
10.448M
10.80%
12.643M
11.17%
14.005M
8.76%
18.678M
2.42%
N/AN/AN/AN/A
EBITDA
Q2Q % growth
-202.98K
91.71%
-3.419M
-17.36%
-2.372M
-2.94%
-1.74M
-337.22%
-104.04K
48.74%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-1.075M
64.72%
-4.079M
-33.68%
-3.195M
-24.14%
-2.639M
-217.16%
-927.69K
13.74%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.05
64.29%
-0.100.0552.18%
Q2 2025
Q2Q % growth
-0.09
52.63%
-0.100.015.46%
Q1 2025
Q2Q % growth
-0.10
54.55%
-0.120.0218.30%
Q4 2024
Q2Q % growth
-0.12
57.14%
-0.160.0426.47%
Q3 2024
Q2Q % growth
-0.14
-7.69%
-0.190.0526.05%
Q2 2024
Q2Q % growth
-0.19
-72.73%
-0.200.016.02%
Q1 2024
Q2Q % growth
-0.22
-120.00%
-0.220.00-0.60%
Q4 2023
Q2Q % growth
-0.28
-64.71%
-0.18-0.10-54.57%
Q3 2023
Q2Q % growth
-0.13
23.53%
-0.12-0.01-12.59%
Q2 2023
Q2Q % growth
-0.11
31.25%
-0.07-0.04-55.39%
Q1 2023
Q2Q % growth
-0.10
41.18%
-0.140.0427.38%
Q4 2022
Q2Q % growth
-0.17
-183.33%
-0.15-0.02-16.96%
Q3 2022
Q2Q % growth
-0.17
-41.67%
-0.15-0.02-14.94%
Q2 2022
Q2Q % growth
-0.16
-33.33%
-0.190.0316.34%
Q1 2022
Q2Q % growth
-0.17
-21.43%
-0.15-0.02-13.63%
Q4 2021
Q2Q % growth
-0.06
-50.00%
-0.110.0546.52%
Q3 2021
Q2Q % growth
-0.12
-9.09%
-0.150.0321.57%
Q2 2021
Q2Q % growth
-0.12
14.29%
-0.150.0320.10%
Q1 2021
Q2Q % growth
-0.14
30.00%
-0.150.013.68%
Q4 2020
Q2Q % growth
-0.04 -0.110.0764.99%
Q3 2020
Q2Q % growth
-0.11 -0.170.0634.74%
Q2 2020
Q2Q % growth
-0.14 -0.220.0835.41%
Q1 2020
Q2Q % growth
-0.20 -0.260.0521.57%
APYX Yearly EPS VS EstimatesAPYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
12.877M
12.10%
12.242M635K5.19%
Q2 2025
Q2Q % growth
11.373M
-6.39%
11.933M-560K-4.69%
Q1 2025
Q2Q % growth
9.43M
-7.95%
9.576M-146K-1.52%
Q4 2024
Q2Q % growth
14.222M
-3.00%
13.656M566K4.14%
Q3 2024
Q2Q % growth
11.487M
-4.08%
11.606M-119K-1.03%
Q2 2024
Q2Q % growth
12.149M
-10.47%
11.982M167K1.39%
Q1 2024
Q2Q % growth
10.244M
-15.63%
9.717M527K5.42%
Q4 2023
Q2Q % growth
14.662M
16.27%
15.145M-483K-3.19%
Q3 2023
Q2Q % growth
11.976M
31.46%
15.678M-3.702M-23.61%
Q2 2023
Q2Q % growth
13.569M
31.87%
14.612M-1.043M-7.14%
Q1 2023
Q2Q % growth
12.142M
-2.79%
11.084M1.058M9.55%
Q4 2022
Q2Q % growth
12.61M
-25.03%
13.195M-585K-4.43%
Q3 2022
Q2Q % growth
9.11M
-22.99%
12.25M-3.14M-25.63%
Q2 2022
Q2Q % growth
10.29M
-8.29%
10.768M-478K-4.44%
Q1 2022
Q2Q % growth
12.49M
44.56%
11.345M1.145M10.09%
Q4 2021
Q2Q % growth
16.82M
46.77%
14.919M1.901M12.74%
Q3 2021
Q2Q % growth
11.83M
70.22%
10.4M1.43M13.75%
Q2 2021
Q2Q % growth
11.22M
160.93%
9.039M2.181M24.13%
Q1 2021
Q2Q % growth
8.64M
72.80%
8.375M265K3.16%
Q4 2020
Q2Q % growth
11.46M 9.808M1.652M16.84%
Q3 2020
Q2Q % growth
6.95M 5.797M1.153M19.89%
Q2 2020
Q2Q % growth
4.3M 2.004M2.296M114.57%
Q1 2020
Q2Q % growth
5M 5.305M-305K-5.75%
APYX Yearly Revenue VS EstimatesAPYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -13.18% -0.08% 14.97%
Revenue2.58% 4.11% 0.88% 3.15%